PORCN and neoplasm: Since many PORCN inhibitors are in clinical trials for solid tumours with active Wnt signalling and radiotherapy is a major treatment option for such tumours, it is likely that PORCN inhibitors would exert beneficial effects in these patients when used concurrently with radiotherapy.